Thermo Fisher to Turn Coronavirus Antibody Testing on Its Head
Thermo Fisher Scientific (NYSE: TMO) is expanding its response to the coronavirus pandemic with a little help from some friends. The Mayo Clinic and WuXi Diagnostics will collaborate with it on the development of the Thermo Fisher Scientific OmniPath COVID-19 Total Antibody ELISA test.
New antibody tests from Abbott, Quest Diagnostics, and some of their peers have already been given emergency use authorization (EUA) by the FDA. These look for relatively simple immunoglobulin G (IgG) antibodies that our immune systems produce in response to SARS-CoV-2. The new test from Thermo Fisher and its collaboration partners will also detect complex immunoglobulin M (IgM) antibodies that appear in the early stage of the immune response.
Image source: Getty Images.
Source Fool.com